Therefore, it has been suggested that unraveling and targeting CXC-chemokine signaling may have significant implications in halting disease progression and assisting in sensitizing tumors to chemotherapeutic and biological agents, given the multiple effects of IL-8 signaling on gastric cells within the tumor microenvironment. The gene discussed is CXCL8; the disease is neoplasm.